
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrating clinical decision support systems for pharmacogenomic testing into clinical routine - a scoping review of designs of user-system interactions in recent system development
Marc Hinderer, Martin Boeker, Sebastian Wagner, et al.
BMC Medical Informatics and Decision Making (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 48
Marc Hinderer, Martin Boeker, Sebastian Wagner, et al.
BMC Medical Informatics and Decision Making (2017) Vol. 17, Iss. 1
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
Kristi Krebs, Lili Milani
Human Genomics (2019) Vol. 13, Iss. 1
Open Access | Times Cited: 157
Kristi Krebs, Lili Milani
Human Genomics (2019) Vol. 13, Iss. 1
Open Access | Times Cited: 157
MIRACUM: Medical Informatics in Research and Care in University Medicine
Hans‐Ulrich Prokosch, Till Acker, Johannes Bernarding, et al.
Methods of Information in Medicine (2018) Vol. 57, Iss. S 01, pp. e82-e91
Open Access | Times Cited: 134
Hans‐Ulrich Prokosch, Till Acker, Johannes Bernarding, et al.
Methods of Information in Medicine (2018) Vol. 57, Iss. S 01, pp. e82-e91
Open Access | Times Cited: 134
Primary Care Physicians’ Knowledge, Attitudes, and Experience with Personal Genetic Testing
Susanne B. Haga, Esther Kim, Rachel A. Myers, et al.
Journal of Personalized Medicine (2019) Vol. 9, Iss. 2, pp. 29-29
Open Access | Times Cited: 78
Susanne B. Haga, Esther Kim, Rachel A. Myers, et al.
Journal of Personalized Medicine (2019) Vol. 9, Iss. 2, pp. 29-29
Open Access | Times Cited: 78
Precision Population Medicine in Primary Care: The Sanford Chip Experience
Kurt D. Christensen, Megan Bell, Carrie L. Blout Zawatsky, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 43
Kurt D. Christensen, Megan Bell, Carrie L. Blout Zawatsky, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 43
Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis
Catherine R. Virelli, Ayeshah G. Mohiuddin, James L. Kennedy
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Catherine R. Virelli, Ayeshah G. Mohiuddin, James L. Kennedy
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries
Kathrin Blagec, Jesse J. Swen, Rudolf Koopmann, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268534-e0268534
Open Access | Times Cited: 32
Kathrin Blagec, Jesse J. Swen, Rudolf Koopmann, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268534-e0268534
Open Access | Times Cited: 32
Evaluating the alert appropriateness of clinical decision support systems in supporting clinical workflow
Olufisayo Olakotan, Maryati Mohd Yusof
Journal of Biomedical Informatics (2020) Vol. 106, pp. 103453-103453
Closed Access | Times Cited: 43
Olufisayo Olakotan, Maryati Mohd Yusof
Journal of Biomedical Informatics (2020) Vol. 106, pp. 103453-103453
Closed Access | Times Cited: 43
Pharmacogenomic testing in paediatrics: Clinical implementation strategies
Charlotte Barker, Gabriella Groeneweg, Anke H. Maitland‐van der Zee, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 10, pp. 4297-4310
Open Access | Times Cited: 35
Charlotte Barker, Gabriella Groeneweg, Anke H. Maitland‐van der Zee, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 10, pp. 4297-4310
Open Access | Times Cited: 35
Pharmacogenomics – a minor rather than major force in clinical medicine
Thomas M. Polasek
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 203-212
Closed Access | Times Cited: 5
Thomas M. Polasek
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 203-212
Closed Access | Times Cited: 5
Pharmacogenetic Testing: A Tool for Personalized Drug Therapy Optimization
Kristina A. Malsagova, Tatiana V. Butkova, Arthur T. Kopylov, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1240-1240
Open Access | Times Cited: 34
Kristina A. Malsagova, Tatiana V. Butkova, Arthur T. Kopylov, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1240-1240
Open Access | Times Cited: 34
Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models
Judith Hayward, John McDermott, Nadeem Qureshi, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 12, pp. 761-776
Open Access | Times Cited: 29
Judith Hayward, John McDermott, Nadeem Qureshi, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 12, pp. 761-776
Open Access | Times Cited: 29
Potential of Whole-Genome Sequencing-Based Pharmacogenetic Profiling
Sylvan M. Caspar, Timo Schneider, Patricia Stoll, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 3, pp. 177-190
Open Access | Times Cited: 27
Sylvan M. Caspar, Timo Schneider, Patricia Stoll, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 3, pp. 177-190
Open Access | Times Cited: 27
Pharmacogenomics in psychiatry – the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing
Sam Mostafa, Thomas M. Polasek, Chad A. Bousman, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 15, pp. 857-867
Open Access | Times Cited: 20
Sam Mostafa, Thomas M. Polasek, Chad A. Bousman, et al.
Pharmacogenomics (2022) Vol. 23, Iss. 15, pp. 857-867
Open Access | Times Cited: 20
The Inclusion of Health Data Standards in the Implementation of Pharmacogenomics Systems: A Scoping Review
Don Roosan, Angela Hwang, Anandi V. Law, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 16, pp. 1191-1202
Open Access | Times Cited: 28
Don Roosan, Angela Hwang, Anandi V. Law, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 16, pp. 1191-1202
Open Access | Times Cited: 28
Strategies and Settings of Clinical Pharmacogenetic Implementation: a Scoping Review of Pharmacogenetics Programs
Tiana Luczak, Sarah Brown, Danielle Armbruster, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 6, pp. 345-364
Closed Access | Times Cited: 24
Tiana Luczak, Sarah Brown, Danielle Armbruster, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 6, pp. 345-364
Closed Access | Times Cited: 24
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty
Charlene L. Preys, Carrie L. Blout Zawatsky, Amanda Massmann, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 10, pp. 539-549
Open Access | Times Cited: 10
Charlene L. Preys, Carrie L. Blout Zawatsky, Amanda Massmann, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 10, pp. 539-549
Open Access | Times Cited: 10
Pharmacogenetics and Psychiatric Care: A Review and Commentary
Merlin G. Butler
JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY (2018) Vol. 2, Iss. 2, pp. 17-24
Open Access | Times Cited: 28
Merlin G. Butler
JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY (2018) Vol. 2, Iss. 2, pp. 17-24
Open Access | Times Cited: 28
Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol
Jason L. Vassy, J. Michael Gaziano, Robert C. Green, et al.
JAMA Network Open (2020) Vol. 3, Iss. 12, pp. e2027092-e2027092
Open Access | Times Cited: 27
Jason L. Vassy, J. Michael Gaziano, Robert C. Green, et al.
JAMA Network Open (2020) Vol. 3, Iss. 12, pp. e2027092-e2027092
Open Access | Times Cited: 27
PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics
Pablo Zubiaur, Gina Mejía‐Abril, Marcos Navares‐Gómez, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3772-3772
Open Access | Times Cited: 23
Pablo Zubiaur, Gina Mejía‐Abril, Marcos Navares‐Gómez, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3772-3772
Open Access | Times Cited: 23
Impact of Pharmacogenomics in Clinical Practice
Nicola Principi, Kyriakoula Petropulacos, Susanna Esposito
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1596-1596
Open Access | Times Cited: 8
Nicola Principi, Kyriakoula Petropulacos, Susanna Esposito
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1596-1596
Open Access | Times Cited: 8
Impact of SLCO 1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review
Jason L. Vassy, Sojeong Chun, Sanjay Advani, et al.
Clinical Pharmacology & Therapeutics (2018) Vol. 106, Iss. 2, pp. 360-373
Open Access | Times Cited: 23
Jason L. Vassy, Sojeong Chun, Sanjay Advani, et al.
Clinical Pharmacology & Therapeutics (2018) Vol. 106, Iss. 2, pp. 360-373
Open Access | Times Cited: 23
Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase
Khoa A. Nguyen, Himalaya Patel, David A. Haggstrom, et al.
BMC Medical Informatics and Decision Making (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 20
Khoa A. Nguyen, Himalaya Patel, David A. Haggstrom, et al.
BMC Medical Informatics and Decision Making (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 20
Implementation of pharmacogenomics: Where are we now?
Samantha Medwid, Richard B. Kim
British Journal of Clinical Pharmacology (2022) Vol. 90, Iss. 8, pp. 1763-1781
Open Access | Times Cited: 11
Samantha Medwid, Richard B. Kim
British Journal of Clinical Pharmacology (2022) Vol. 90, Iss. 8, pp. 1763-1781
Open Access | Times Cited: 11
FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy
Rossana Roncato, Lisa Dal Cin, Silvia Mezzalira, et al.
Genes (2019) Vol. 10, Iss. 4, pp. 276-276
Open Access | Times Cited: 18
Rossana Roncato, Lisa Dal Cin, Silvia Mezzalira, et al.
Genes (2019) Vol. 10, Iss. 4, pp. 276-276
Open Access | Times Cited: 18
Acceptance of clinical decision support systems in Saudi healthcare organisations
Soliman Aljarboa, Shah Jahan Miah
Information Development (2021) Vol. 39, Iss. 1, pp. 86-106
Closed Access | Times Cited: 14
Soliman Aljarboa, Shah Jahan Miah
Information Development (2021) Vol. 39, Iss. 1, pp. 86-106
Closed Access | Times Cited: 14